356 related articles for article (PubMed ID: 22480730)
1. Gene delivery to bone.
Evans CH
Adv Drug Deliv Rev; 2012 Sep; 64(12):1331-40. PubMed ID: 22480730
[TBL] [Abstract][Full Text] [Related]
2. Bone Regeneration Using Gene-Activated Matrices.
D'Mello S; Atluri K; Geary SM; Hong L; Elangovan S; Salem AK
AAPS J; 2017 Jan; 19(1):43-53. PubMed ID: 27655418
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy approaches to regenerating bone.
Kimelman Bleich N; Kallai I; Lieberman JR; Schwarz EM; Pelled G; Gazit D
Adv Drug Deliv Rev; 2012 Sep; 64(12):1320-30. PubMed ID: 22429662
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Mesenchymal Stem Cell Sheets Overexpressing BMP-7 in Canine Critical-Sized Bone Defects.
Kim Y; Kang BJ; Kim WH; Yun HS; Kweon OK
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018197
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy approaches for bone regeneration.
Franceschi RT; Yang S; Rutherford RB; Krebsbach PH; Zhao M; Wang D
Cells Tissues Organs; 2004; 176(1-3):95-108. PubMed ID: 14745239
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
Bougioukli S; Saitta B; Sugiyama O; Tang AH; Elphingstone J; Evseenko D; Lieberman JR
Hum Gene Ther; 2019 Jul; 30(7):906-917. PubMed ID: 30773946
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for the regeneration of bone.
Evans C
Injury; 2011 Jun; 42(6):599-604. PubMed ID: 21489526
[TBL] [Abstract][Full Text] [Related]
8. Applications and Prospects of Non-viral Vectors in Bone Regeneration.
Yang W; Wang F; Feng L; Yan S; Guo R
Curr Gene Ther; 2018; 18(1):21-28. PubMed ID: 29493451
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration.
Koh JT; Zhao Z; Wang Z; Lewis IS; Krebsbach PH; Franceschi RT
J Dent Res; 2008 Sep; 87(9):845-9. PubMed ID: 18719211
[TBL] [Abstract][Full Text] [Related]
10. Cancellous bone allograft seeded with human mesenchymal stromal cells: a potential good manufacturing practice-grade tool for the regeneration of bone defects.
Stiehler M; Seib FP; Rauh J; Goedecke A; Werner C; Bornhäuser M; Günther KP; Bernstein P
Cytotherapy; 2010 Sep; 12(5):658-68. PubMed ID: 20429788
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model.
Blum JS; Barry MA; Mikos AG; Jansen JA
Hum Gene Ther; 2003 Dec; 14(18):1689-701. PubMed ID: 14670121
[TBL] [Abstract][Full Text] [Related]
12. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type.
Gugala Z; Olmsted-Davis EA; Gannon FH; Lindsey RW; Davis AR
Gene Ther; 2003 Aug; 10(16):1289-96. PubMed ID: 12883525
[TBL] [Abstract][Full Text] [Related]
13. An expedited approach for sustained delivery of bone morphogenetic protein-7 to bone defects using gene activated fragments of subcutaneous fat.
Betz VM; Betz OB; Rosin T; Keller A; Thirion C; Salomon M; Manthey S; Augat P; Jansson V; Müller PE; Rammelt S; Zwipp H
J Gene Med; 2016 Aug; 18(8):199-207. PubMed ID: 27373764
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for repair and regeneration of bone and cartilage.
Grol MW; Lee BH
Curr Opin Pharmacol; 2018 Jun; 40():59-66. PubMed ID: 29621661
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
16. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
[TBL] [Abstract][Full Text] [Related]
17. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration.
Aslan H; Zilberman Y; Arbeli V; Sheyn D; Matan Y; Liebergall M; Li JZ; Helm GA; Gazit D; Gazit Z
Tissue Eng; 2006 Apr; 12(4):877-89. PubMed ID: 16674300
[TBL] [Abstract][Full Text] [Related]
18. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
19. Bone tissue engineering by gene delivery.
Kofron MD; Laurencin CT
Adv Drug Deliv Rev; 2006 Jul; 58(4):555-76. PubMed ID: 16790291
[TBL] [Abstract][Full Text] [Related]
20. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
